RxDoctor Payments Data

Marian Macsai

Ophthalmology · Glenview, ILNPI 1306851183

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by AbbVie at 58.2% of the total. Reporting peaked in 2019 at $38,061 and has fallen 99.7% since, to $115 in 2023. Among ophthalmology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$74,158in general payments, 2019–2025

Across 117 payments — averaging $633.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$43K
  • Novartis$9K
  • Shire North American Group Inc$8K
  • Dompe US, Inc.$4K
  • Aerie Pharmaceuticals, Inc.$4K
  • Ocular Therapeutix, Inc.$2K
  • plus $4K from 11 others

What the payments were for

  • Consulting fees$25,85035%
  • Speaking & faculty fees$40,57555%
  • Travel & lodging$3,4485%
  • Food & beverage$4,2466%
  • Gifts$390%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$74,158 in reported general payments places this provider in the 95th percentile of 773 ophthalmology providers in Illinois.

See all ophthalmology providers in Illinois

Other ophthalmology in Glenview

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →